|
DAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.83999515413325E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8961499037573E-12 |
| Normal-vs-Stage2 |
1.75492999999749E-05 |
| Normal-vs-Stage3 |
6.48159999999676E-05 |
| Normal-vs-Stage4 |
8.46230000000059E-05 |
| Stage1-vs-Stage2 |
6.385800E-01 |
| Stage1-vs-Stage3 |
6.131900E-02 |
| Stage1-vs-Stage4 |
9.588400E-01 |
| Stage2-vs-Stage3 |
3.613000E-01 |
| Stage2-vs-Stage4 |
7.895400E-01 |
| Stage3-vs-Stage4 |
2.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47930001581642E-10 |
| Normal-vs-AfricanAmerican |
2.31940022743515E-10 |
| Normal-vs-Asian |
1.477030E-03 |
| Caucasian-vs-AfricanAmerican |
6.435400E-01 |
| Caucasian-vs-Asian |
5.673200E-01 |
| AfricanAmerican-vs-Asian |
5.949600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66267000167863E-12 |
| Normal-vs-Female |
1.59402999999614E-05 |
| Male-vs-Female |
3.925900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.72470000082382E-08 |
| Normal-vs-Extreme_Weight |
4.1254000215929E-10 |
| Normal-vs-Obese |
5.69849999965122E-07 |
| Normal-vs-Extreme_Obese |
4.89749996113176E-09 |
| Normal_Weight-vs-Extreme_Weight |
8.859800E-01 |
| Normal_Weight-vs-Obese |
3.460000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.331600E-02 |
| Extreme_Weight-vs-Obese |
1.963440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.311800E-02 |
| Obese-vs-Extreme_Obese |
3.862400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.565300E-04 |
| Normal-vs-Age(41-60Yrs) |
6.13340001009988E-09 |
| Normal-vs-Age(61-80Yrs) |
1.61870516990348E-12 |
| Normal-vs-Age(81-100Yrs) |
5.354900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.482200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.754000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.900400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.714180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.712200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.224400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.20497011946964E-12 |
| Normal-VS-Type2 PRCC |
3.2732999644125E-09 |
| Normal-VS-KIRP CIMP |
2.021200E-04 |
| Normal-VS-Unclassified PRCC |
3.94729999997345E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.604800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.501000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.767980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.889800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.386200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.183000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11639997036184E-09 |
| Normal-vs-N1 |
1.99680000001479E-06 |
| Normal-vs-N2 |
1.078230E-02 |
| N0-vs-N1 |
8.040800E-01 |
| N0-vs-N2 |
9.017400E-01 |
| N1-vs-N2 |
7.967400E-01 |
|
|
